Search for Clinical Trial Results
Optic Nerve Glioma - 25 Studies Found
Status | Study |
Completed |
Study Name: Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy Condition:
Date: 2008-05-14 Interventions: |
Active, not recruiting |
Study Name: Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma Condition:
|
Terminated |
Study Name: Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas Condition:
Interventions: Drug: Sorafenib (Nexavar) Sorafenib (in tablet form) will |
Recruiting |
Study Name: Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma Condition:
|
Recruiting |
Study Name: Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors Condition:
|
Active, not recruiting |
Study Name: Pomalidomide in Treating Younger Patients With Recurrent, Progressive or Refractory Central Nervous System Tumors Condition:
|
Withdrawn |
Study Name: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors Condition:
|
Terminated |
Study Name: 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas Condition:
|
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condition:
|
Completed |
Study Name: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Condition:
|